Company profile
Numab Therapeutics AG
Delivering next-generation multispecific therapeutics in inflammation and oncology
- Industry
- Biotechnology Research
- Employees
- 78
- Headquarters
- Horgen
- Founded
- 2011
- Office locations
- 1
Numab Therapeutics AG company summary
Numab Therapeutics AG is a company in the Biotechnology Research industry, headquartered in Horgen, founded in 2011. On LinkedIn the company has around 78 employees.
What technology does Numab Therapeutics AG use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Numab Therapeutics AG
Numab Therapeutics is a biopharmaceutical company focused on the discovery and development of next-generation multispecific antibody-based therapeutics for inflammation and oncology. With over a decade of innovation, Numab has built a highly differentiated multispecific antibody platform integrating λ-cap™ and MATCH™ technologies, advanced Fc engineering, and integrated immunogenicity-reduction strategies. Leveraging deep in-house engineering expertise, Numab is advancing a diversified pipeline of multispecific antibodies with first- and best-in-class potential and has established a strong track record of strategic partnerships with leading pharmaceutical companies.
Where is Numab Therapeutics AG located?
Numab Therapeutics AG lists 1 location.
Compare companies similar to Numab Therapeutics AG
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Numab Therapeutics AG numab.com | Biotechnology Research | 78 | 2011 | Horgen |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Numab Therapeutics AG
What does Numab Therapeutics AG do?
Numab Therapeutics is a biopharmaceutical company focused on the discovery and development of next-generation multispecific antibody-based therapeutics for inflammation and oncology. With over a decade of innovation, Numab has built a highly differentiated multispecific antibody platform integrating λ-cap™ and MATCH™ technologies, advanced Fc engineering, and integrated immunogenicity-reduction strategies. Leveraging deep in-house engineering expertise, Numab is advancing a diversified pipeline of multispecific antibodies with first- and best-in-class potential and has established a strong track record of strategic partnerships with leading pharmaceutical companies.
How many employees does Numab Therapeutics AG have?
Numab Therapeutics AG has around 78 employees on LinkedIn.
Where is Numab Therapeutics AG headquartered?
Numab Therapeutics AG is headquartered in Horgen.
When was Numab Therapeutics AG founded?
Numab Therapeutics AG was founded in 2011.
Build a lead list from companies like Numab Therapeutics AG
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.